Paid Clinical Trials in Vermont

Vermont has 211 paid clinical trials enrolling now across cities including Burlington, Saint Johnsbury and Berlin Corners. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Vermont include National Cancer Institute (NCI), University of Vermont and University of Vermont Medical Center, running studies across oncology, cardiology, neurology, and more. The most actively recruiting conditions are Heart Failure, Acute Myeloid Leukemia, Cystic Fibrosis, Stage IV Lung Cancer AJCC v8 — browse the full list or use the filters to match your diagnosis. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .

Filter results
Filter results
Recruitment status
Phase
Sex
Age

Newly added in Vermont

Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.

187 clinical trials

ELEVATE-HFpEF Clinical Study

for Heart Failure With Preserved Ejection Fraction (HFpEF)
Sites in Burlington +25 more locations
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Sex: All·Age: 40+
Code: NCT06678841·Recruiting·Listed Nov 2024
Apply to this trial

Common conditions studied in Vermont

  • Heart Failure (7 active studies)
  • Acute Myeloid Leukemia (6 active studies)
  • Cystic Fibrosis (6 active studies)
  • Cancer (4 active studies)
  • Stage IV Lung Cancer AJCC v8 (4 active studies)
  • Anatomic Stage II Breast Cancer AJCC v8 (3 active studies)

Leading research sponsors in Vermont

  • National Cancer Institute (NCI)
  • University of Vermont
  • University of Vermont Medical Center
  • NRG Oncology
  • Alliance for Clinical Trials in Oncology

Frequently asked questions

How many paid clinical trials are currently recruiting in Vermont?

There are approximately 211 recruiting clinical trials in Vermont listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.

Do clinical trials in Vermont pay participants?

Most recruiting trials in Vermont compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.

Who can participate in a clinical trial in Vermont?

Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.

What conditions are most commonly studied in Vermont?

The most common conditions under active study in Vermont include Heart Failure (7), Acute Myeloid Leukemia (6), Cystic Fibrosis (6), Cancer (4), among many others. Browse the list above to explore every recruiting trial.

Are there clinical trials for healthy volunteers in Vermont?

Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Vermont on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.

How do I enroll in a clinical trial in Vermont?

Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.

Browse more clinical trials

All cities in Vermont

Burlington, VT(159)Saint Johnsbury, VT(29)Berlin Corners, VT(23)White River Junction, VT(14)Colchester, VT(9)Bennington, VT(4)South Burlington, VT(3)Montpelier, VT(1)Multiple Locations, VT(1)Rutland, VT(1)Williston, VT(1)Winooski, VT(1)Woodstock, VT(1)

Related healthcare resources in Vermont

Behavioral health news in VermontLatest Vermont clinical trials research report

Trials by condition in Vermont

Heart Failure· 7Acute Myeloid Leukemia· 6Breast Cancer· 3